Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $81.5300 (-2.46%) ($80.8000 - $83.4300) on Thu. Sep. 22, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.6% (three month average) | RSI | 28 | Latest Price | $81.5300(-2.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -2% a day on average for past five trading days. | Weekly Trend | LGND declines -4.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(50%) IWN(49%) IWO(49%) IWC(47%) IBB(45%) | Factors Impacting LGND price | LGND will decline at least -1.3% in a week (0% probabilities). UUP(-17%) VXX(-16%) TBT(-7%) UNG(-6%) VIXM(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.3% (StdDev 2.6%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $76.66(-5.97%) | Resistance Level | $91.62 | 5 Day Moving Average | $84.92(-3.99%) | 10 Day Moving Average | $88.33(-7.7%) | 20 Day Moving Average | $91.62(-11.01%) | To recent high | -24.3% | To recent low | 1.3% | Market Cap | $1.31b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |